Recruiting

Biospecimen Collection

Sponsor:

iSpecimen Inc

Code:

NCT03848962

Conditions

Cancer

Healthy

Gastrointestinal Complication

Autoimmune Diseases

Infectious Disease

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

Study Details

Brief summary:

iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagnostic test and instrumentation development and validation; therapeutics development; other medical research including the impact that various specimen collection and handling methods and conditions have on research results; and in education such as researcher or physician training (collectively "research").

Conditions

Cancer

Healthy

Gastrointestinal Complication

Autoimmune Diseases

Infectious Disease

Study ID

NCT03848962

Start date

Jun 30, 2016

Status verified date

Nov, 2022

Completion date

Dec 31, 2026

Anticipated

Primary completion date

Dec 31, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Individual is developmentally aged 7 years old and above for RUO collections (only)
  • Individual meets requirements of a current request for research materials from iSpecimen
  • If a blood collection will be performed as part of the screening process or RUO collection, the individual's health will be assessed by medical staff through medical record review, clinical exam, and/or the review of an updated medical history as provided by the participant
  • Individual has reviewed and signed a consent form for an RUO specimen collection if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf.
  • Individual has reviewed and signed a consent form for remnant specimen usage in research if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf

Exclusion Criteria:

  • Subjects that do not meet the inclusion criteria outlined above.

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Arms

Subjects for observational study

Various conditions \& healthy subjects

Primary outcome measure

  • Collection of Biospecimens for Novel Research Uses [ Time Frame: 10 years ]

Central Contacts and Locations

Central contacts

Emily L Hubbard

2567970003ehubbard@ispecimen.com

Locations

iSpecimen

Recruiting

Huntsville, Alabama, United States, 35801

Contacts

Emily L Hubbard

256-797-0003ehubbard@ispecimen.com

More Information

Sponsor

iSpecimen Inc

Last update posted

Nov 9, 2022

Last verified

Nov, 2022

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by iSpecimen Inc on 2022-11-09.